|
Volumn 95, Issue 1, 2001, Pages 72-73
|
Assessing the risk of benzimidazole therapy during pregnancy
a a |
Author keywords
Albendazole; Benzimidazoles; Chemotherapy; Filariasis; Pregnancy; Wuchereria bancrofti
|
Indexed keywords
ALBENDAZOLE;
BENZIMIDAZOLE;
DIETHYLCARBAMAZINE;
FOLIC ACID;
HEMOGLOBIN;
IRON;
IVERMECTIN;
MEBENDAZOLE;
PLACEBO;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CONGENITAL DISORDER;
DEVELOPING COUNTRY;
DISEASE TRANSMISSION;
DRUG CONTRAINDICATION;
DRUG POTENTIATION;
DRUG SAFETY;
EMBRYO;
EMBRYO DEVELOPMENT;
EMBRYOTOXICITY;
FETUS;
FILARIASIS;
FIRST TRIMESTER PREGNANCY;
GENERAL PRACTITIONER;
HEALTH PROGRAM;
HOOKWORM INFECTION;
HUMAN;
LACTATION;
NONHUMAN;
PREGNANCY;
PRENATAL DRUG EXPOSURE;
RABBIT;
RAT;
RISK ASSESSMENT;
TERATOGENICITY;
WORLD HEALTH ORGANIZATION;
WUCHERERIA BANCROFTI;
ANCYLOSTOMATOIDEA;
ANIMALIA;
ORYCTOLAGUS CUNICULUS;
WUCHERERIA;
WUCHERERIA BANCROFTI;
|
EID: 0035725327
PISSN: 00359203
EISSN: None
Source Type: Journal
DOI: 10.1016/S0035-9203(01)90338-4 Document Type: Article |
Times cited : (64)
|
References (9)
|